| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,
,,
*
T Cell Signal Transduction Laboratory, Hospital for Special Surgery, Weill Medical College of Cornell University, the
Department of Human Genetics and
Immunology Program, Memorial Sloan-Kettering Cancer Center, and the
Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021
TCR and CD28 costimulatory receptor-cooperative induction of T cell IL-2 secretion is dependent upon activation of mitogen-activated protein (MAP) kinases. Using yeast-hybrid technology, we cloned a novel CD28 cytoplasmic tail (CD28 CYT) interacting protein, MAP kinase phosphatase-6 (MKP6), which we demonstrate inactivates MAP kinases. Several lines of evidence indicate that MKP6 plays an important functional role in CD28 costimulatory signaling. First, in human peripheral blood T cells (PBT), expression of MKP6 is strongly up-regulated by CD28 costimulation. Second, transfer of dominant-negative MKP6 to PBT with the use of retroviruses primes PBT for the secretion of substantially larger quantities of IL-2, specifically in response to CD28 costimulation. A similar enhancement of IL-2 secretion is observed neither in response to TCR plus CD2 costimulatory receptor engagement nor in response to other mitogenic stimuli such as phorbol ester and ionomycin. Furthermore, this hypersensitivity to CD28 costimulation is associated with CD28-mediated hyperactivation of MAP kinases. Third, a retroviral transduced chimeric receptor with a CD28 CYT that is specifically unable to bind MKP6 costimulates considerably larger quantities of IL-2 from PBT than a similar transduced chimeric receptor that contains a wild-type CD28 CYT. Taken together, these results suggest that MKP6 functions as a novel negative-feedback regulator of CD28 costimulatory signaling that controls the activation of MAP kinases.
This article has been cited by other articles:
|
|
 |
|
  A. R. Raimondi, A. Molinolo, and J. S. Gutkind Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model Cancer Res., May 15, 2009; 69(10): 4159 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jurek, K. Amagasaki, A. Gembarska, C.-H. Heldin, and J. Lennartsson Negative and Positive Regulation of MAPK Phosphatase 3 Controls Platelet-derived Growth Factor-induced Erk Activation J. Biol. Chem., February 13, 2009; 284(7): 4626 - 4634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Boutros, E. Chevet, and P. Metrakos Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer Pharmacol. Rev., September 1, 2008; 60(3): 261 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Schuit and D. J. Drucker {beta}-Cell Replication by Loosening the Brakes of Glucagon-Like Peptide-1 Receptor Signaling Diabetes, March 1, 2008; 57(3): 529 - 531. [Full Text] [PDF]
|
|
|
|
|
|
S. Klinger, C. Poussin, M.-B. Debril, W. Dolci, P. A. Halban, and B. Thorens Increasing GLP-1-Induced {beta}-Cell Proliferation by Silencing the Negative Regulators of Signaling cAMP Response Element Modulator-{alpha} and DUSP14 Diabetes, March 1, 2008; 57(3): 584 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Salojin and T. Oravecz Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes J. Leukoc. Biol., April 1, 2007; 81(4): 860 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lang, M. Hammer, and J. Mages DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response J. Immunol., December 1, 2006; 177(11): 7497 - 7504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Kowolik, M. S. Topp, S. Gonzalez, T. Pfeiffer, S. Olivares, N. Gonzalez, D. D. Smith, S. J. Forman, M. C. Jensen, and L. J.N. Cooper CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells. Cancer Res., November 15, 2006; 66(22): 10995 - 11004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Graham, M. P. Bell, C. J. Huntoon, M. D. Griffin, X. Tai, A. Singer, and D. J. McKean CD28 Ligation Costimulates Cell Death but Not Maturation of Double-Positive Thymocytes due to Defective ERK MAPK Signaling J. Immunol., November 1, 2006; 177(9): 6098 - 6107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Liu The Yins of T Cell Activation Sci. Signal., January 4, 2005; 2005(265): re1 - re1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. Chen, R. Luche, B. Wei, and N. K. Tonks Characterization of Two Distinct Dual Specificity Phosphatases Encoded in Alternative Open Reading Frames of a Single Gene Located on Human Chromosome 10q22.2 J. Biol. Chem., October 1, 2004; 279(40): 41404 - 41413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sadra, T. Cinek, and J. B. Imboden Translocation of CD28 to lipid rafts and costimulation of IL-2 PNAS, August 3, 2004; 101(31): 11422 - 11427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Alonso, S. Narisawa, J. Bogetz, L. Tautz, R. Hadzic, H. Huynh, S. Williams, A. Gjorloff-Wingren, M. C. D. Bremer, L. J. Holsinger, et al. VHY, a Novel Myristoylated Testis-restricted Dual Specificity Protein Phosphatase Related to VHX J. Biol. Chem., July 30, 2004; 279(31): 32586 - 32591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Cook, L. Albacker, A. August, and A. J. Henderson CD28-dependent HIV-1 Transcription Is Associated with Vav, Rac, and NF-{kappa}B Activation J. Biol. Chem., September 12, 2003; 278(37): 35812 - 35818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Parry, C. A. Rumbley, L. H. Vandenberghe, C. H. June, and J. L. Riley CD28 and Inducible Costimulatory Protein Src Homology 2 Binding Domains Show Distinct Regulation of Phosphatidylinositol 3-Kinase, Bcl-xL, and IL-2 Expression in Primary Human CD4 T Lymphocytes J. Immunol., July 1, 2003; 171(1): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-R. Chen, J. Han, R. Kori, A.-N. T. Kong, and T.-H. Tan Phenylethyl Isothiocyanate Induces Apoptotic Signaling via Suppressing Phosphatase Activity against c-Jun N-terminal Kinase J. Biol. Chem., October 11, 2002; 277(42): 39334 - 39342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zama, R. Aoki, T. Kamimoto, K. Inoue, Y. Ikeda, and M. Hagiwara A Novel Dual Specificity Phosphatase SKRP1 Interacts with the MAPK Kinase MKK7 and Inactivates the JNK MAPK Pathway. IMPLICATION FOR THE PRECISE REGULATION OF THE PARTICULAR MAPK PATHWAY J. Biol. Chem., June 21, 2002; 277(26): 23909 - 23918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zama, R. Aoki, T. Kamimoto, K. Inoue, Y. Ikeda, and M. Hagiwara Scaffold Role of a Mitogen-activated Protein Kinase Phosphatase, SKRP1, for the JNK Signaling Pathway J. Biol. Chem., June 21, 2002; 277(26): 23919 - 23926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Masuda, H. Shima, M. Watanabe, and K. Kikuchi MKP-7, a Novel Mitogen-activated Protein Kinase Phosphatase, Functions as a Shuttle Protein J. Biol. Chem., October 12, 2001; 276(42): 39002 - 39011. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
